No smoke without fire as Pfizer questions French political ban on Champix
This article was originally published in Scrip
Executive Summary
France has stopped reimbursement of Pfizer's anti-smoking pill Champix/Chantix (varenicline). The country's health minister Xavier Bertrand said the decision was made because of questions over the product's safety.